A phase 1/2, dose‐escalation trial of deferasirox for the treatment of iron overload in HFE‐related hereditary hemochromatosis

Overview of attention for article published in Hepatology, July 2010

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

twitter: 1 X user

patent: 1 patent

Citations

dimensions_citation: 111 Dimensions

Readers on

mendeley: 61 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

Deferasirox for the treatment of hereditary hemochromatosis

Grant EP-2026801-B1

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.